DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Regular insulin
Regular insulin
Humulin
LANTUS® (Insulin Glargine [Rdna Origin] Injection)
Comparison of Adjunctive Therapy with Metformin and Acarbose in Patients with Type-1 Diabetes Mellitus
Diabetes Mellitus: Patterns of Pharmaceutical Use in Manitoba
Type 2 Diabetes Adult Outpatient Insulin Guidelines
Use of Inhaled Human Insulin in Patients with Diabetes Mellitus Meghan K
Step-Wise Dosing and Titration of Insulin for Type 2 Diabetes in the Ambulatory Setting Last Update 5/2010
Combination Use of Insulin and Incretins in Type 2 Diabetes
Combination Therapies with Insulin in Type 2 Diabetes
Guide to Starting and Adjusting Insulin for Type 2 Diabetes*
Inpatient Care | Lantus (Insulin Glargine Injection) 100 Units/Ml
Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying
Preferred Drug List Drug Class Review Announcement
Insulin Pocketcard™
New Tools in the Toolbox for Type 2 Diabetes
LANTUS® Must Not Be Diluted Or Mixed with Any Other Insulin Or Solution
Growing Our Future in Diabetes Care: Where Are We Now and Where Are We Going?
Insulin and Insulin Analogues Table
Top View
Low Cost Options for Treating Type 2 Diabetes Mellitus
Gestational Diabetes Mellitus: Safety and Efficacy of Regular Insulin and Metformin During Pregnancy
Insulin Aspart PI
How to Switch Between Insulin Products Switching Insulins Should Always Be Done with Prescriber Approval and Close Monitoring
Johns Hopkins Hospital • Glucose Management Committee
Humulin® R Cartridges and Kwikpen
Pre-Surgery Diabetes Medications
Type 2 Diabetes: Latest Drug Approvals and Use of the Newer Agents
Diabetes, Tools and Tips of the Trade
Commercial Insulin Changes Eff 12/1/16
How to Switch Between Insulin Products Switching Insulins Should Always Be Done with Prescriber Approval and Close Monitoring
NPH (Humulin N), Insulin Glargine (Lantus)
Supplementary Data
Interim Report for H1 2020
Insulin Administration
Report Is Produced and Published by the Manitoba Centre for Health Policy (MCHP)
Low Utilisation of Diabetes Medicines in Iran, Despite Their Affordability (2000–2012): a Time-Series and Benchmarking Study
The Official Journal of ATTD Advanced Technologies
Insulin Stewardship
Diabetes Mellitus
Prevalence, Drug Treatment and Glycemic Control
Euglycemic Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After
Lecture 4 Learning Objectives: Lec 4
Therapeutic Class Overview Insulins
The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor
2018 AAHA Diabetes Management Guidelines for Dogs and Cats*
GLP-1 Agonists
A Case of Euglycaemic Diabetic Ketoacidosis in a Patient Treated with Canogliflozin
Mixing Insulins: 10 Units of Regular and 20 Units of NPH
The Delivery of Ambulatory Diabetes Care to Children and Adolescents with Diabetes
Novolog® Insulin Aspart (Rdna Origin)
Diabetes Echo 11/12/2020 Beyond Basal Insulin Therapy
FDA Approves New Indication for Exenatide
Volume 16, No. 1 January/February 2018
XERS Xeris Pharmaceuticals / 10 Aug 20 / 2020 Q2 Earnings Call Transcript
Liraglutide Improves Glucose Control in Type 1 Diabetes
Diabetes Meds on a Budget
One Hundred Years of Insulin Therapy
CASE STUDIES Report
Diabetic Medications
Exogenous Insulin Products
Switching Between Insulin Products in Disaster Response Situations Approved by the American Diabetes Association, the Endocrine Society and JDRF - August 2018
Antihyperglycemic Agents Comparison Chart
Initiating Bedtime Insulin
Medication Titration Algorithm for Type 2 Diabetes ¹ < 65 Yrs <7% 70-130 ≥ 65 Yrs <8% 100-160 Goals
Preferred Drug List (PDL)
INSULIN MARKET PROFILE April 2016 INSULIN MARKET PROFILE April 2016
Insulin Therapy for Type 2 Diabetes: Rescue, Augmentation, and Replacement of Beta-Cell Function JENNIFER A
Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus
New Long-Acting Basal Insulins -August 2017